ArticleFrontiers in oncology2022

Case report: Dramatic response to alectinib in a lung adenosquamous carcinoma patient harbouring a novel CPE-ALK fusion.

Yanyan Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.